The intersection of substance use with broader public health concerns.
Public Health
Conceptual framework and evaluation of a prevention experience based on sports activities
ISSUP Argentina invites you to participate in a webinar on the conceptual framework and evaluation of a prevention experience based on sports activities.
The webinar will take place on Monday, September 13, 2021 at 6:00 p.m. (Argentina Time).

Webinar:Evidence-Based Community Interventions

Webinar: Evidence-Based Community Interventions
ISSUP Argentina invites you to participate in a webinar on evidence-based community interventions.
The webinar will take place on Thursday, August 19, 2021 at 6:00 p.m. (Argentina Time).

SRNT 28th Annual Meeting
The Society of Research on Nicotine and Tobacco (SRNT) 2022 Annual Meeting may be a hybrid (part in person, part virtual) or entirely virtual, depending on how things play out in the coming months.
The event will take place in Edinburgh, Scotland from the 2-5th of March 2022.
Abstract submissions will open on July 7, 2021, and will close on August 11, 2021.

International Conference on Hepatitis Care in Substance Users (INHSU)
The 9th International Conference on Health and Hepatitis Care in Substance Users will take place in Australia, via a hybrid delivery model.
Join delegates from all over the world, with 20+ sessions from world-leading experts over three days.

Joint Australasian Sexual Health and HIV&AIDS Conferences (online)
Joint Australasian HIV&AIDS and Sexual Health Conferences will once again be hosted in a virtual format between 6 to 9 September, following the success of last year’s inaugural virtual conferences.

Prevalence and factors related to alcohol consumption in pregnant adolescents: a systematic review
Prison and drugs in Europe: Current and future challenges

Kenya Launches National Guidelines on Drug Use Prevention

Dame Carol Black's Independent Review of Drugs - Part 2
Collective Voice are delighted to welcome Dame Carol Black as the keynote speaker of our next webinar, presenting the findings from the second part of her Independent Review of Drugs.
Dame Carol's presentation will be followed by comments from Rosanna O'Connor, Interim Director, Health Improvement at Public Health England.